Programmable NIR Responsive Nanocomposite Enables Noninvasive Intratympanic Delivery of Dexamethasone to Reverse Cisplatin Induced Hearing Loss

Search results

• Active

  PII: Printed Intelligence Infrastructure

  Toivakka, M. (Principal Investigator), Xu, C. (Co-Principal Investigator), Bobacka, J. (Co-Principal Investigator), Viitala, T. (Co-Principal Investigator), Rosenholm, J. (Co-Principal Investigator), Österbacka, R. (Co-Principal Investigator), Anttu, N. (Co-Principal Investigator), Huynh, T. P. (Co-Principal Investigator), Peltonen, J. (Co-Principal Investigator), Wang, X. (Co-Principal Investigator), Zhang, H. (Co-Principal Investigator) & Wilen, C.-E. (Co-Principal Investigator)

  Research Council of Finland

  01/01/24 → 31/12/28

  Project: Research Council of Finland/Other Research Councils